Vermersch P - Search Results

1

Alpha-fodrin autoantibodies in the differential diagnosis of MS and Sjögren syndrome.

de Seze J, Dubucquoi S, Fauchais AL, Matthias T, Devos D, Castelnovo G, Stojkovic T, Ferriby D, Hachulla E, Labauge P, Lefranc D, Hatron PY, Vermersch P, Witte T. de Seze J, et al. Among authors: vermersch p. Neurology. 2003 Jul 22;61(2):268-9. doi: 10.1212/01.wnl.0000071217.95981.0e. Neurology. 2003. PMID: 12874419 No abstract available.

2

Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates.

de Seze J, Stojkovic T, Gauvrit JY, Devos D, Ayachi M, Cassim F, Saint Michel T, Pruvo JP, Guieu JD, Vermersch P. de Seze J, et al. Among authors: vermersch p. J Neurol. 2001 Apr;248(4):297-303. doi: 10.1007/s004150170204. J Neurol. 2001. PMID: 11374094

3

Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases.

de Seze J, Stojkovic T, Breteau G, Lucas C, Michon-Pasturel U, Gauvrit JY, Hachulla E, Mounier-Vehier F, Pruvo JP, Leys D, Destée A, Hatron PY, Vermersch P. de Seze J, et al. Among authors: vermersch p. Brain. 2001 Aug;124(Pt 8):1509-21. doi: 10.1093/brain/124.8.1509. Brain. 2001. PMID: 11459743

4

Long-term follow-up of neurosarcoidosis.

Ferriby D, de Seze J, Stojkovic T, Hachulla E, Wallaert B, Destée A, Hatron PY, Vermersch P. Ferriby D, et al. Among authors: vermersch p. Neurology. 2001 Sep 11;57(5):927-9. doi: 10.1212/wnl.57.5.927. Neurology. 2001. PMID: 11552036

5

The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis.

de Seze J, Devos D, Castelnovo G, Labauge P, Dubucquoi S, Stojkovic T, Ferriby D, Vermersch P. de Seze J, et al. Among authors: vermersch p. Neurology. 2001 Oct 23;57(8):1359-63. doi: 10.1212/wnl.57.8.1359. Neurology. 2001. PMID: 11673571

6

Interferon beta1a (Avonex) treatment in multiple sclerosis: similarity of effect on progression of disability in patients with mild and moderate disability.

Vermersch P, de Seze J, Stojkovic T, Hautecoeur P; G-SEP (Groupe Septentrional d'Etudes et de Recherches sur la SEP). Vermersch P, et al. J Neurol. 2002 Feb;249(2):184-7. doi: 10.1007/pl00007862. J Neurol. 2002. PMID: 11985384 Clinical Trial.

7

Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in cerebellar syndrome secondary to multiple sclerosis.

Monaca-Charley C, Stojkovic T, Duhamel A, De Seze J, Ferriby D, Vermersch P. Monaca-Charley C, et al. Among authors: vermersch p. J Neurol. 2003 Oct;250(10):1190-4. doi: 10.1007/s00415-003-0176-3. J Neurol. 2003. PMID: 14586600 Clinical Trial.

8

Prospective study of patients presenting with acute partial transverse myelopathy.

Cordonnier C, de Seze J, Breteau G, Ferriby D, Michelin E, Stojkovic T, Pruvo JP, Vermersch P. Cordonnier C, et al. Among authors: vermersch p. J Neurol. 2003 Dec;250(12):1447-52. doi: 10.1007/s00415-003-0242-x. J Neurol. 2003. PMID: 14673577

9

CSF isoelectrofocusing in a large cohort of MS and other neurological diseases.

Bourahoui A, De Seze J, Guttierez R, Onraed B, Hennache B, Ferriby D, Stojkovic T, Vermersch P. Bourahoui A, et al. Among authors: vermersch p. Eur J Neurol. 2004 Aug;11(8):525-9. doi: 10.1111/j.1468-1331.2004.00822.x. Eur J Neurol. 2004. PMID: 15272896

10

Creutzfeldt-Jakob disease: neurophysiologic visual impairments.

de Seze J, Hache JC, Vermersch P, Arndt CF, Maurage CA, Pasquier F, Laplanche JL, Ruchoux MM, Leys D, Destée A, Petit H. de Seze J, et al. Among authors: vermersch p. Neurology. 1998 Oct;51(4):962-7. doi: 10.1212/wnl.51.4.962. Neurology. 1998. PMID: 9781513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters